Lupin Limited — JV/Acquisition, 02-04-2025: Acquisition

Lupin Healthcare (UK) Limited has acquired 100% of Renascience Pharma Limited, a UK-based pharmaceutical company, for GBP 12.3 million in cash. This acquisition enhances Lupin's portfolio of specialty pharmaceuticals, focusing on niche products like injectables for infectious diseases and treatments for ear pain and cardiovascular issues, which currently face no local generic competition. The strategic move aims to extend Lupin's presence in the UK market and improve access to critical medicines, aligning with their mission of delivering sustainable healthcare solutions.